Key Highlights: Implications: Sun Pharma’s acquisition of Innovcare looks like a portfolio-building move in India: for about ₹271.2 crore, Sun is buying a growing busin...
Key Highlights: Implications: The all-cash ₹188 crore acquisition gives Alivira immediate access to BioForLife’s established Italian pet-care business in nutraceuticals...
Key Highlights: Implications: Sun Pharma is making its biggest strategic pivot yet with the planned all‑cash takeover of Organon, using the deal to jump from an India‑anchor...
